CENTRAL RETINAL ARTERY OCCLUSION
Clinical trials for CENTRAL RETINAL ARTERY OCCLUSION explained in plain language.
Never miss a new study
Get alerted when new CENTRAL RETINAL ARTERY OCCLUSION trials appear
Sign up with your email to follow new studies for CENTRAL RETINAL ARTERY OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race against time: drug trial aims to halt sudden blindness
Disease control CompletedThis study tested if a fast-acting clot-busting drug could save vision in people who suddenly lose sight due to a blocked artery in the eye. 81 patients were randomly assigned to receive either the drug (tenecteplase) or aspirin within 4.5 hours of symptoms starting. The main goa…
Matched conditions: CENTRAL RETINAL ARTERY OCCLUSION
Phase: PHASE3 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Apr 02, 2026 05:11 UTC
-
Experimental eye injections aim to rescue vision after sudden artery blockage
Disease control CompletedThis study tested whether a new drug called KUS121, injected directly into the eye, could help restore vision in people who suddenly lost sight due to a blocked retinal artery. Seventeen participants received either the real drug or a sham (fake) injection within two days of thei…
Matched conditions: CENTRAL RETINAL ARTERY OCCLUSION
Phase: PHASE2 • Sponsor: Kyoto Drug Discovery and Development Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC